Loading viewer...
investor_presentation
Format: PDF investor_presentation
Prelude Therapeutics is a precision medicine company developing small molecule therapies for cancer treatment. The company's pipeline includes candidates such as PRT1419, PRT2527, PRT3645, PRT3789, and an oral SMARCA2 candidate in clinical development. This presentation outlines the company's diversified pipeline, commercial opportunities, and R&D capabilities in oncology.
investor_presentation
37 Pages
investor_presentation
42 Pages
Timken Company
Zentalis Pharmaceuticals Investor Presentation — August 2022
investor_presentationinvestor_presentation
44 Pages
Zentalis Pharmaceuticals, Inc.